Pharmacological characterization of nucleotide P2Y receptors on endothelial cells of the mouse aorta
- 1 September 2005
- journal article
- Published by Wiley in British Journal of Pharmacology
- Vol. 146 (2), 288-295
- https://doi.org/10.1038/sj.bjp.0706326
Abstract
Nucleotides regulate various effects including vascular tone. This study was aimed to characterize P2Y receptors on endothelial cells of the aorta of C57BL6 mice. Five adjacent segments (width 2 mm) of the thoracic aorta were mounted in organ baths to measure isometric force development. Nucleotides evoked complete (adenosine 5' triphosphate (ATP), uridine 5' triphosphate (UTP), uridine 5' diphosphate (UDP); >90%) or partial (adenosine 5' diphosphate (ADP)) relaxation of phenylephrine precontracted thoracic aortic rings of C57BL6 mice. Relaxation was abolished by removal of the endothelium and was strongly suppressed (>90%) by inhibitors of nitric oxide synthesis. The rank order of potency was: UDP approximately UTP approximately ADP>adenosine 5'-[gamma-thio] triphosphate (ATPgammaS)>ATP, with respective pD2 values of 6.31, 6.24, 6.22, 5.82 and 5.40. These results are compatible with the presence of P2Y1 (ADP>ATP), P2Y2 or P2Y4 (ATP and UTP) and P2Y6 (UDP) receptors. P2Y4 receptors were not involved, since P2Y4-deficient mice displayed unaltered responses to ATP and UTP. The purinergic receptor antagonist suramin exerted surmountable antagonism for all agonists. Its apparent pKb for ATP (4.53+/-0.07) was compatible with literature, but the pKb for UTP (5.19+/-0.03) was significantly higher. This discrepancy suggests that UTP activates supplementary non-P2Y2 receptor subtype(s). Further, pyridoxal-phosphate-6-azophenyl-2'-4'-disulphonic acid (PPADS) showed surmountable (UTP, UDP), nonsurmountable (ADP) or no antagonism (ATP). Finally, 2'-deoxy-N6-methyladenosine3',5'-bisphosphate (MRS2179) inhibited ADP-evoked relaxation only. Taken together, these results point to the presence of functional P2Y1 (ADP), P2Y2 (ATP, UTP) and P2Y6 (UDP) receptors on murine aorta endothelial cells. The identity of the receptor(s) mediating the action of UTP is not fully clear and other P2Y subtypes might be involved in UTP-evoked vasodilatation.This publication has 35 references indexed in Scilit:
- ADP Receptor P2Y 12 Is Expressed in Vascular Smooth Muscle Cells and Stimulates Contraction in Human Blood VesselsArteriosclerosis, Thrombosis, and Vascular Biology, 2004
- Characterization of Purine Receptors in Mouse Thoracic AortaJournal of Cardiovascular Pharmacology, 2004
- ATP and UTP responses of cultured rat aortic smooth muscle cells revisited: dominance of P2Y2 receptorsBritish Journal of Pharmacology, 2003
- P2X4, P2Y1 and P2Y2 receptors on rat alveolar macrophagesBritish Journal of Pharmacology, 2003
- Pharmacological Characterization of the Human P2Y13 ReceptorMolecular Pharmacology, 2003
- Extracellular nucleotides induce vasodilatation in human arteries via prostaglandins, nitric oxide and endothelium‐derived hyperpolarising factorBritish Journal of Pharmacology, 2003
- Characterization of the UDP-glucose receptor (re-named here the P2Y14 receptor) adds diversity to the P2Y receptor familyTrends in Pharmacological Sciences, 2003
- Characterization and Channel Coupling of the P2Y12Nucleotide Receptor of Brain Capillary Endothelial CellsPublished by Elsevier BV ,2002
- Nucleotide‐mediated relaxation in guinea‐pig aorta: selective inhibition by MRS2179British Journal of Pharmacology, 2002
- Cloning, Functional Expression and Tissue Distribution of the Human P2Y6ReceptorBiochemical and Biophysical Research Communications, 1996